5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.42▼ | 5.36▲ | 5.30▲ | 5.37▲ | 4.90▲ |
MA10 | 5.39▲ | 5.39▲ | 5.56▼ | 4.75▲ | 5.53▼ |
MA20 | 5.45▼ | 5.78▼ | 5.61▼ | 5.17▲ | 5.85▼ |
MA50 | 5.89▼ | 5.16▲ | 4.74▲ | 6.33▼ | 5.16▲ |
MA100 | 5.48▼ | 4.74▲ | 4.95▲ | 6.03▼ | 31.52▼ |
MA200 | 4.79▲ | 5.24▲ | 6.08▼ | 5.02▲ | 116.53▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.026▲ | -0.102▼ | -0.111▼ | 0.217▲ | -0.051▼ |
RSI | 43.665▼ | 48.656▼ | 51.669▲ | 49.822▼ | 48.035▼ |
STOCH | 81.200▲ | 30.847 | 22.931 | 63.030 | 13.937▼ |
WILL %R | -43.511 | -69.167 | -76.875▼ | -41.032 | -77.854▼ |
CCI | 29.315 | -39.244 | -57.373 | 89.655 | -48.807 |
RSI | $CAMP RSI(14) Crossed Below 50 | Set Alert |
Tuesday, January 21, 2025 04:00 PM
CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing ...
|
Tuesday, January 21, 2025 01:39 AM
On Monday, CalAmp Corp. (NASDAQ:CAMP) received an upgrade from Northland, shifting from a Market Perform rating to Outperform. The firm has set a new price target for CalAmp at ...
|
Wednesday, January 15, 2025 08:00 AM
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
23/01/25 | 5.88 | 5.88 | 5.00 | 5.44 | 55,232 |
22/01/25 | 6.49 | 6.49 | 5.01 | 5.80 | 139,900 |
21/01/25 | 4.62 | 6.7899 | 4.62 | 6.54 | 320,718 |
17/01/25 | 4.52 | 4.625 | 4.42 | 4.62 | 21,480 |
16/01/25 | 4.34 | 4.70 | 4.21 | 4.45 | 57,700 |
15/01/25 | 3.75 | 4.67 | 3.57 | 4.41 | 58,479 |
14/01/25 | 4.01 | 4.12 | 3.50 | 3.74 | 50,883 |
13/01/25 | 4.30 | 4.46 | 3.69 | 3.95 | 113,900 |
10/01/25 | 4.36 | 4.51 | 4.04 | 4.06 | 192,700 |
08/01/25 | 4.47 | 4.88 | 4.41 | 4.45 | 38,200 |
|
|
||||
|
|
||||
|
|